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1. Introduction 
Tuberculosis (TB) is one of the most prevalent infectious diseases in the world, particularly in 
developing countries. The high incidence and mortality of TB in these countries mainly resides 
in the limited financial resources, the emergence of multiresistant strains and the spread of 
HIV infections. The key element for controlling TB is a rapid and early diagnosis which 
ensures the correct treatment and eradication of the infection source in the community. 
Current strategies for the development of a rapid and accurate diagnosis address 3 major 
objectives: improving the present diagnostic tools through better knowledge, developing new 
tests and increasing the accessibility to such diagnostic possibilities (Who Strategic Directions, 
2006). The gold standard of diagnosis in TB is the identification of mycobacteria in the 
pathologic product using acid-fast smear microscopy and mycobacterial culture. Nevertheless 
the bacteriologic diagnosis is presently inefficient due to increasing number of smear-negative 
TB forms. This has led to the development of various complementary diagnostic methods such 
immunologic assays. The aim of the present chapter is to outline the literature data on the 
importance of the immunologic diagnosis in neurotuberculosis, a lethal localization of TB. It 
presents the current immunological assays and their practical value in the diagnosis of 
neurotuberculosis as complementary methods.  
2. General data 
Neurotuberculosis is represented by various central nervous system (CNS) tuberculous 
manifestations including : tuberculoma, tuberculous abscess, meningoencephalitis , spinal 
arachnoiditis and cerebral miliary tuberculosis. This diverse neurological frame mostly 
emerges as a result of the invasive potential as well as of the immune pathogeny of 
neurotuberculosis. The difficulty in the diagnosis of neurotuberculosis lies in the atypical 
clinical presentation and non-specific changes recorded by various diagnostic assays. The 
bacteriological exams of the cerebrospinal fluid (CSF) are still regarded as the sole 
diagnostic tools in the confirmation of neurotuberculosis. Nevertheless the bacteriological 
assay in neurological forms of TB has a low sensitivity and a considerable delay. As a rule, 
owing to the rapid evolution and increased mortality, the suspected neurotuberculosis 
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patients frequently receive antituberculous treatment before bacteriological confirmation 
(Donald & Schoeman, 2004). A complete antituberculous treatment requires 6-12 months, 
during which serious adverse reactions could occur. On the other hand nontuberculous CNS 
infections with different treatment and high mortality could be overlooked. Therefore 
multiple research studies based on new diagnostic methods have been developed over the 
last 30 years aiming to improve the diagnostic efficiency in neurotuberculosis. 
3. Diagnostic methods in neurotuberculosis 
CSF analysis represents the basic element in the diagnosis of neurotuberculosis. The 
isolation and identification of mycobacteria in CSF are crucial for the diagnosis of 
neurotuberculosis. However as the CSF is a paucibacillar product, these methods often fail. 
All the same the CSF could present characteristic cytological and chemical changes which 
could be suggestive for the neurotuberculosis diagnosis in a specific clinical context. In 
several cases, especially in children and immunosupressed patients, the cytochemical 
changes of the CSF lack even these particular findings and the neurotuberculosis diagnosis 
is then ommited. During the past decades various complementary methods have been 
implemented to assist these difficulties. These currently include : nucleic acid amplification 
tests (NAATs), CSF adenosindeaminase (ADA) detection and immunologic assays. 
3.1 Advantages and disadvantages of current diagnostic techniques in 
neurotuberculosis 
Below are the main findings, advantages and disadvantages of each current diagnostic 
method in neurotuberculosis (Desai et al, 2006; Sonmeza et al, 2008; Nyendak et al, 2009; 
Davies & Pai 2008) 
a. CSF cytology. Main findings: at the onset mixed pleocytosis with mainly 
lymphocytes(80-90%) and the presence of neutrophils (10-20%); in the later stages, only 
lymphocytes.  
Advantages: rapid, inexpensive, sensitive method. Disadvantages: 1) Variable CSF cytology in 
the evolution of the disease, 2) Many atypical CSF aspects at the onset or throughout the 
evolution in immunodepressed hosts and children 3)Low specificity; 4)Normal CSF 
cytology cannot rule out localized forms of neurotuberculosis 
b. Biochemical CSF exam. Main findings: high CSF protein level and low glucose.  
Advantages: rapid, inexpensive. Disadvantages: 1) Very low specificity: many infections of the 
CNS share similar changes ; 2) CSF biochemical analysis is normal in localized forms of 
neurotuberculosis. 
c. Bacteriologic CSF exam.  
CSF smear. Main findings: the CSF smear detects mycobacteria using acid-fast bacilli stains 
(Ziehl-Neelsen or the Kinyoun method) as well as fluorescence staining.  
Advantages: rapid, inexpensive, simple, specific, low technical demand. Disadvantages:  
1) Very low sensitivity of 13-53%; nevertheless, fluorescence microscopy and certain 
processing methods have been developed to improve the sensitivity; 2) The CSF smear 
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cannot distinguish between different species of mycobacteria ; moreover, it is difficult to 
detect nontuberculous mycobacteria; 3) The procesessing is prone to contamination with 
environmental or water-borne saprophitic mycobacteria; 4) Results depend on the CSF 
volume (a positive result requires >6ml of CSF) and on the number of samples (repeated 
analysis of lumbar punctures increases diagnostic yield); 5) False negative smear results in 
localized forms of cerebral TB. 
CSF culture. Main findings: isolation and identification of mycobacteria on selective media 
(solid or liquid media). 
Advantages: 1) Represents the definitive proof of active TB (gold standard). 2) Enables the 
performance of an antibiogram; 3) better sensitivity, than the CSF smear. Disadvantages: 1) 
Sensitivity depends on the number of samples, CSF volume and mycobacteria loading (CSF 
enrichment techniques could be used); 2) Large differences between media on efficiency and 
price; 3) Adequate laboratory infrastructure and trained personnel are necessary; 4) 
Detection requires minimum 14 days even on selective media; 5) Negative CSF culture in 
localized neurotuberculosis.  
d. Nucleic acid amplification tests (NAATs). Main findings: detect mycobacteria nucleic 
acid in serum and CSF using the PCR assay.  
Advantages: NAATs exhibits a high specificity (88%-100%), good positive predictive value 
and rapid processing. Due to its specificity it could be used for treatment monitoring. 
Disadvantages: 1) NAATs have a highly variable sensitivity and low negative predictive 
value, especially in smear-negative and extrapulmonary TB; the sensitivity of the PCR 
method (33% to 90%) is highly dependent on the mycobacteria loading and variable for each 
PCR technique; 2) PCR becomes rapidly negative after treatment; 3) In-house NAATs 
produces highly variable results compared to commercial, standardized NAATs. 
Nevertheless, commercial NAATs show a potential role in confirming the diagnosis of TB 
meningitis, although their overall low sensitivity precludes the use of these tests to rule out 
the diagnosis with certainty; 4) The high price makes them prohibitive in poor countries 
with the highest prevalence of TB. 
e. The adenosine deaminase (ADA) detection 
Advantages: rapid; inexpensive; high diagnostic accuracy. Disadvantages: 1) Low specificity: it 
cannot rule out bacterial meningitis. 2) Not standardized. 
f. Histologic exam. Main findings: reveals tissue mycobacteria and characteristic 
granulomatous aspects.  
Advantages: 1) Very high specificity. 2) The main diagnosis method for localised cerebral TB. 
Disadvantages: 1) Invasive method; 2) Histology does not distinguish between mycobacteria 
or different granulomatous diseases; 4)Belated result (requires one or two days) 
g. Imaging methods. Main findings: indicates complications of neurotuberculosis 
(hydrocephalus, vasculitis) and localized forms of neurotuberculosis. Advantages: 
improves the differential diagnosis and treatment evaluation. Disadvantages:  
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Conclusion: None of the current methods meets the criteria required by an efficient 
diagnostic test: rapid, accurate and readily applicable. Treatment in neurotuberculosis is 
therefore implemented according to the association of epidemiological, clinical criteria, 
bacteriologic CSF examination and different complementary laboratory methods dependent 
on the technical level of each laboratory. The decision on which tests to use should consider 
country-level technical facilities and other relevant factors, such as cost and availability. The 
lack of standardisation in the use of these methods renders their comparison more difficult. 
3.2 Reason for the development of immunologic assays in neurotuberculosis 
Unlike latent TB, neurotuberculosis is characterized by active CNS lesions accompanied by 
an intense cellular and humoral immune response. Both T cells and B cells are active during 
mycobacteria replication suggesting the potential use of immune markers in cerebral TB. 
Immune diagnostic tools also assessed antigens released by M.tbc in the CSF or specific 
antibodies. Beginning with 1990, numerous antigens and antibodies were screened for the 
diagnosis of neurotuberculosis in endemic areas. Studies on these methods proved a good 
specificity and simple, inexpensive and rapid results. Nevertheless the low sensitivity and 
the development of molecular techniques decreased the importance of these methods in 
neurotuberculosis diagnosis. The immunological diagnosis continues to be considered in TB 
endemic areas due to the increasing number of immunological biomarkers detection (Walzl 
et al, 2011). Over the past years, T cell-based IFNg release assays (IGRAs) performed on T 
cell isolated from the CSF, were found senzitive and specific for TB meningitis. IGRAs 
restored the interest in the immunological methods for TB diagnosis even in countries with 
high financial support. (Thomas et al, 2008). 
3.3 The advantages and disadvantages of immunologic diagnostic methods in the 
diagnosis of neurotuberculosis 
a. Determination of mycobacterial antigens or antimycobacterial antibodies in serum and 
CSF fluid. (Thomas et al, 2008; Patel et al, 2010) 
Advantages: 1) Rapid , inexpensive, simple technique, minimal training requirements 
compared to molecular methods. 2) Specific detection of the intrathecal synthesis of 
antimycobacterial antibodies and of mycobacterial antigens in the CSF.  
Disadvantages: 1) Highly inconsistent estimates of sensitivity and specificity correlated with 
the method used, detected type of antigen or antibody and mycobacteria load; however 
combinations of select antigens provide higher sensitivity compared to single antigens.  
2) False negative results particularly in immunodepressed hosts; 3) Specificity can be 
affected by cross reactions between different mycobacteria or other bacterial species 
(Nocardia, Leishmania); 4) Some methods (ELISA) require specific equipment, skilled 
technicians and refrigerated reagents. 
b. IFN-γ release assays (IGRAs) The two methods presently used are QuantiFERON-Gold 
(QFT-G) method and T-SPOT.TB method. Both can substitute the tuberculin skin test 
(TST) in routine clinical practice, especially where BCG vaccination is prevalent.  
Avantages: rapid and specific. 2) Applied in few studies of neurotuberculosis with a 
sensitivity of 90% and specificity of 100% in cases of negative bacteriological TB meningitis.  
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Disadvantages: 1) Requires appropiate lab-facility; 2) Expensive; 3) T cell lymphopenia and 
anergy resulting from disseminated TB or advanced HIV infection, lead to the lack of 
ELISPOT responses. 4) False negative results in patients with atypical CSF (few 
lymphocytes). 5) False positive results in the case of blood contamination during puncture.  
Conclusion. The immunological diagnosis in neurotuberculosis reflects the present 
knowledge related to the immune pathogenesis of TB. Addition of new immunologic data 
and a more complex interpretation of the results could improve the diagnostic value of these 
methods.  
4. Imunologic response in NTB 
TB is primarily a pulmonary disease. The protective immunity in infections with M.tbc is 
ensured by the macrophageal activity, CD4T cell response and Th1 cytokines. Consequently, 
the immune response frequently leads to the formation of granuloma, an organized and 
efficient form of defence. The granulomas include mycobacteria with a modified metabolism 
and potential of active replication which increases in case of immunodepression. The 
granulomas adjacent to the meninges or cerebral vessels increase the risk of CSF 
mycobacteria invasion. Mycobacteria reaching the subarachnoidial space release antigens 
and induce an intense inflammatory response. Since 1990, these antigens have been 
acknowledged as potential markers for the diagnosis of TB meningitis. 
4.1 Mycobacterial antigens (general data, classification, role) 
M.tbc encodes about 4000 proteins. As mycobacteria are extremely dynamic they release a 
variable number of antigens according to the clinical form of TB, the duration of the 
infection and the host immune response. The recognition of relevant mycobacterial antigens 
by T cell subsets is an essential step in triggering the protective immunity in TB. A 
functional classification of these antigens is presently unavailable, nor is the selection of 
antigens for the development of efficient serological diagnostic tools. Sequencing of the 
M.tbc genome in 1998 and the knowledge in proteogenomics led to the identification of 
numerous immunogenic antigens specific for M. tbc and M .bovis. These specific antigens 
differ from environmental mycobacterias or BCG vaccine strains and could be used in the 
immunologic TB diagnosis. However no specific antigen or set of antigens has been yet 
recognized in TB and no set of antigens has been established for diagnosis with confidence. 
The release of a certain antigen is induced by a large number of factors such as the type of 
infection (active or inactive), the host immune status (imunocompetent or 
immunodeppressed), local immune metabolism or ph conditions, mycobacteria viability 
(viable mycobacteria release other antigens than dormant bacilli), mycobacteria virulence 
and the infection site. The immunogenicity of these antigens also differs: only a small 
number of the antigens released in the culture media (25%) induced the synthesis of specific 
antibodies. (Samanich et al, 2000). The variability of released antigens under different 
conditions and their immunogenicity hinders an accurate selection and represents a serious 
obstacle in the immunodiagnostic development of TB. A cocktail combining a large number 
of antigens (10 to 12 recombinant antigens or poly-proteins) appears to be a reasonable 
choice for increasing both the sensitivity and the specificity of immunologic diagnostic 
methods (Raja et al, 2008). The classification and nomenclature of mycobacteria antigens is 
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not unitary. There are more names and classifications for one antigen depending on 
localization (cellular wall, cellular membrane and cytoplasm antigens) and structure (lipids, 
proteins, polysaccharides and their complexes). Proteic antigens are secreted in active 
lesions and have proved a great potential in the serological diagnosis, either alone or in 
poly-protein complexes (Houghton et al, 2002) , while glycolipidic antigens are released in 
immunodepressed hosts especially. A detailed presentation of mycobacteria antigens 
belongs to Young (Yang et al, 1992). Several of these proteic antigens have already been 
included in diagnostic tests for neurotuberculosis: antigens of 38 kDa, 16 kDa, 88 kDa, 
MPT51, CFP-10, antigen 85B (associated to the protein 30-31 kDa), lipoarabinomannan 
(LAM), antigen A60, antigen 5, cord factor. The roles assigned to mycobacteria antigens are 
often contradictory and not fully understood. The documented activity of mycobacteria 
antigens is diverse: enhancing the immune response (antigen 85, P320, A60) , triggering the 
delayed-type hypersensitivity (proteic antigens), interfering with the adhesion of 
mycobacteria on host cells, promoting phagosome-lysososme fusion. Certain antigens 
(LAM, 30kDa antigen, antigen 6) also induce cellular immunodepression by inhibiting 
various functions of the macrophages, or T Lymphocytes and assisting in the formation of 
granulomas.  
4.2 Antimycobacterial antibodies (general data, relevance, dynamics)  
M. tbc is resistant to antimycobacterial antibodies. Stimulation of the humoral immunity 
using polysaccharide conjugated vaccines has not been efficient and antimycobacterial 
antibodies are not considered protective (Glatman-Freedman et al, 2000). Nevertheless their 
presence could influence the immune response. Thus the presence of B lymphocytes 
surrounding granulomas suggests the involvement of humoral immunity in latent forms of 
TB .The appearance of plasmocytes in the CSF also suggests a potential role of specific 
antibodies in TB meningitis. Numerous studies have attempted to identify specific 
antibodies in active TB but the present data is incomplete. The antigenic variability of 
mycobacteria is mirrored by the heterogenity of the released antibiodies. The repertoir of 
released antibodies appears to be diverse and correlated to many factors (the lesion’s 
evolution and localization, the immune status etc) (Davidow et al, 2005). As in the case of 
antigens, the type of the released antibodies in different hosts and different forms of TB is 
unpredictable. Thus anti 38kDa are elevated in pulmonary TB while LAM antibodies and 
anti 16 kda increase in the CSF of patients with TB meningitis; anti 38 kDa have been 
associated with a poor outcome, while anti 19kda suggested a good prognosis. Anti38kDa 
are released in the presence of cavitary lesions and have not been found in patients who do 
not present such lesions such as immunodeppresed hosts. Anti 85 complex are present in 
large quantities in disease forms confirmed by positive smear as well as in severe forms. By 
comparison, lower amounts were found in forms with negative smears or minimal lesions. 
(Wiker & Harboe, 1992). Antibody responses are correlated with the bacillary load. Under 
these circumstances the level of IgG was regarded by some authors as an index for the 
antigenic load with possible implications in treatment follow-up (Fadda et al, 1992). The 
present knowledge on the role of antimycobacterial antibodies is the result of numerous 
immunologic diagnostic studies but their implication in the TB pathogenesis is still little 
known. IgM antibodies were found in different groups of patients with TB including 
vaccinated patients and are frequently found in HIV patients. Their presence marks the 
colonization with mycobacteria or the risk of TB relapse. IgA antibodies are rarely found. 
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They are detected in the CSF, pericardial and pleural liquid. They could appear in a state of 
anergy or in the absence of IgG antibodies, sometimes indicating an aberrant immune 
response Th2 like. Immune complexes are frequently correlated with IgA antibodies and 
severe disease. A protective effect of IgA of short duration has been observed in the early 
stages of TB. IgG antibodies appear during chronic disease; high titres are maintained even 
during treatment. These are the main type of antibodies observed in neurotuberculosis 
(Maes, 1991). 
The dynamic synthesis of antimycobacterial antibodies  
Different stimuli were documented to trigger the antimycobacterial antibodies in the 
primary versus post primary infection or active versus inactive TB. The hummoral immune 
response following BCG vaccination indicates that IgM anti PPD increase progressively 
until the third month, followed by an increase of IgG. The antibody dynamics in TB 
infection could be similar (Maes et al, 1989), but it also depends on the clinical form and 
treatment starting. IgA serum antibodies appear immediately after IgM and precede IgG, 
but the CSF dynamics could vary. IgG antibodies are prevalent in both active and inactive 
cases (Kaplan & Chase, 1980). During treatment for primary tuberculosis antimycobacteria 
antibodies are present in low titres, exhibit a slow increase and are directed against a low 
number of antigens. (Kaplan & Chase, 1980). Only 11-46% of patients display an initial titre 
of antibodies, but the number of cases subsequently increases to 60%. In relapse forms of TB 
the serum reacts with a larger number of antigens, the IgG titre is higher and rapidly 
increases under treatment. A detectable IgG titre is initially recorded in 66% of patients but 
reaches 75-100% of patients in the later stages. Similar conclusions were published in other 
studies in which TB relapse forms produced a positive serology in 100% of patients 
compared to 11% in primary TB (Julian et al, 1997). Seroconversion under treatment in patients 
with TB exceeds 3-8 weeks in patients with a negative titre at the onset, while in those with 
positive onset titres the antibody increase is rapid and immediate. The titre of 
antimycobacterial antibodies in the serum and CSF is higher in treated compared to untreated 
patients (Kaplan & Chase 1980). Some authors consider that in primary TB the maximum titre 
could emerge after 3 months of treatment. The presence of antimycobacterial antibodies in 
large quantities in relapse as well as in the treated forms is a significant advantage in the 
serodiagnosis of neurotuberculosis (as the latter frequently occurs as a relapse). The main 
disadvantage is related to the slow antibody dynamics in primary infections. 
4.3 The intrathecal synthesis of antimycobacterial antibodies in NTB  
CNS dissemination of mycobacteria is assisted by alveolar macrophages and their 
interaction with epithelial cells. Although the hematomeningeal barrier ensures the CNS 
protection from systemic immune reactions, the nevrax is still the site of intense 
inflammatory reactions. The intracerebral immune reactions are supported by the 
phagocytic cells of CNS, such as astrocytes and endothelial cells. (de Micco & Toga, 1988) 
The complex of astrocytes and endothelial cells is also connected to microglial cells, 
oligodendrocytes and hematopoetic stem cells. All these cells could activate lymphocytes 
and release inflammatory cytokines. Moreover, the lymphocytes crossing the 
hematomeningeal barrier synthesize intrathecal immunoglobulins (Ig). The intrathecal 
synthesis of specific antibodies was first observed in neurotuberculosis by Kinman. He 
showed that the stimulation of CSF lymphocytes by PPD leads to their intense proliferation 
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(Kinnman et al, 1981). Subsequent studies revealed a local production of antimycobacterial 
antibodies anti PPD in the CSF (Kalish et al, 1983). In 1990, Sindic proved the presence of 
IgG in the CSF against the antigen of M. tbc H37Ra and A60 (Sindic et al, 1990)  In this study 
antimycobacterial antibodies appeared in the subarachnoid space as early as 15 days after 
clinical onset and persisted up to 69 months. The delayed immune response after the 
disappearance of the antigenic stimulus could persist as a result of immune disorders of 
active B cells clones. A similar response was also observed in other nontuberculous 
meningoencephalitis even 8 years later. IgG generally dominate the CNS humoral immune 
response, but in some cases IgA are also present (Felgenhauer & Schädlich, 1987). The 
antimycobacterial antibodies synthesis could be detected and quantified in the CSF, 
resulting in titres that could be higher in the CSF compared to the serum. Furthermore the 
increase of the Ig index in the CSF is a proof of the local synthesis of antimycobacterial 
antibodies (Kinman et al, 1981). The intrathecal synthesis of antimycobacterial antibodies 
released in the CSF is specific for cerebral TB and thus represents a solid argument in favor 
of the neurotuberculosis diagnosis. 
5. Immunologic methods used in the diagnosis of neurotuberculosis 
Immunological assays are rapid and easy to process but their use in TB is disputed due to 
contradictory results on sensitivity. Nevertheless, immunologic methods could be 
considered as complementary diagnostic tools especially in poor areas and smear-negative 
CSF neurotuberculosis. The most commonly used serological assay in neurotuberculosis is 
enzyme-linked immunosorbent assay (ELISA). Rapid methods (such as immunodot) are 
only seldom used. ELISA is automated and able to simultaneously analyse a high number of 
samples and different antibodies (Ig G, IgM or IgA). The evaluation of serological assays 
requires the accuracy of the following parameters: the sensitivity (probability of a positive 
test in people with neurotuberculosis), the specificity (probability of a negative test in 
uninfected people), the positive predictive value (probability that the person is infected 
when the test is positive) and the negative predictive value (probability that the person is 
uninfected when the test is negative). 
5.1 The enzyme-immuno-assay (ELISA) technique 
ELISA technique was first introduced in the serological diagnosis of TB in 1976. It detectes 
the antigen/antibody-enzyme linked complexes, with the antigen affixed to a solid 
adsorbent surface. Despite its highly variable sensitivity and specificity, studies on 
pulmonary TB proved that it is rapid and simple to process, suggesting its use in the 
extrapulmonary TB diagnosis. There are several comercial ELISA kits (Anda Biological 
using antigen A60, Omerga Pathozyme TB using antigen 38 kDa, Pathozyme TB complex 
with antigen 38 kDa and antigen 16 kDa, Pathozyme Myco with antigen 38 kDa and 
lypopolissaharidic antigen), and various in-house antibody-ELISA detection tests. 
Numerous ELISA studies were performed for the detection of different antigens and 
antibodies released in the pulmonary and extrapulmonary TB. Daniel and Debanne 
published a reference study in 1987 (Daniel & Debanne, 1987) analysing ELISA results in 
different forms of TB. They concluded that ELISA sensitivity of 25-100% and specificity of 
76-100% were highly variable depending on the used antigen. A subsequent systematic 
revue on ELISA studies also revealed an extremely variable sensitivity of 0-100% and 
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specificity of 59-100% in pulmonary TB and modest results in TB meningitis (sensitivity of 
48% and specificity of 82%) (Steingart et al, 2007). 
5.2 Interferon-γ-release assays (IGRAs) 
There are currently 2 methods measuring the IFN-γ released by sensitized T cells: 
QuantiFERON-Gold In Tube (Cellestis Ltd) which measures IFN-γ-released in whole blood 
following ex vivo stimulation with ESAT-6, CFP-10 and TB 7.7 antigens and the T-SPOT.TB 
method (Oxford Immunotec Ltd) which measures IFN-γ-released by peripheral blood 
mononuclear cells following ex vivo stimulation with ESAT-6 and CFP-10. These 2 methods 
were initially approved for the diagnosis of latent TB, displaying a higher efficiency 
compared to tuberculin skin tests (TST). Their use was later extended for the diagnosis of 
active TB including HIV-infected patients. Recent studies on TB meningitis using both 
methods revealed only modest results. (Thomas et al, 2008, Patel et al, 2010). Thus the 
specificity in the diagnosis of active TB was generally low (59-79%) while the sensitivity was 
between 79% (non HIV patients) and 64% (HIV patients) (Sester et al, 2011). Nevertheless 
more optimistic results in TB meningitis were also reported (Murakami et al, 2008). 
5.3 Other techniques used in the immune diagnosis of neurotuberculosis 
The immunoblot technique is based on the electrophoretic separation of proteins (antigens 
or antibodies from serum or CSF), blotting for separate fractions on nitrocelulosis and 
identification of each proteic fraction with a specific anti-serum conjugated with a complex 
of streptavidin-biotin preoxidase (calitative reaction). The immunoblot technique was 
previously used by several authors in the diagnosis of mycobacterial infections. Most 
antigens recorded in these studies weighted between 30-45 kDa. However, only a part of the 
serum antigens identified in pulmonary TB were also recorded in the CSF in TB meningitis. 
In a study by Mathai the patients with TB meningitis presented 27 kDa, 30kDa, 45 kDa and 
5kDa M.tbc antigens (Mathai et al, 1994). The latter was found in another study in 70% of 
patients with TB meningitis (Mathai et al, 1991). Patil also identified 30-40kDa antigens in 
the CSF but lower amounts of 14kDa and 18-25kDa antigens (Patil et al, 1996). Katti 
identified mostly 30-32kDa and 71kDa antigens in the CSF of patients with TB meningitis 
(Katti, 2001). Literature data also reveals the predominance of 30kDa antigen in the CSF. 
Research proved that 30 kDa protein is also a member of the Ag 85 complex (Ag 85 A and 
Ag 85 B), an antigen frequently detected in TB meningitis. This emphasizes the importance 
of 30 kDa antigen as a CSF marker in various forms of TB meningitis. ImmunoDOT is an 
rapid-test format, dipstick ELISA that allows patients to be tested for multiple parameters 
simultaneously. Up to five or six different tests may be completed simultaneously on a 
single sample, making it ideal for users who require fast, and reliable diagnostic tests in a 
single patient format. ImmunoDot or other rapid techniques are suitable for low CSF 
volumes and limited resources laboratories. Haemagglutination assays such as reverse 
passive haemagglutination (RPHA) using polyclonal or monoclonal antibodies, could be 
used in the serum and CSF, with a variable sensitivity in the diagnosis of TB meningitis. 
(Venkatesh et al, 2007). The use of a polyclonal serum generally proved more efficient. The 
main limitation of this method was connected to the variable sensitivity (50-94%) and to the 
short shelf-life of red-cell labelled antibodies; both listed drawbacks could be amended 
(Katti, 2001). The method is interesting from the perspective of using a single sample for the 
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detection of both antibodies and antigens in biologic products and for measuring antigens 
and antibody dilutions needed in treatment monitoring. Radioimmunoassay (RIA) has 
been used for the TB diagnosis since 1987, with variable results. The method could follow 
the antigens level in the CSF during treatment which enables its use in treatment monitoring 
(Kadival et al, 1987). In conclusion, neurotuberculosis presently employs a wide range 
ofimmunologic diagnostic techniques. Their results however are not influenced by the 
method as much as by the detected antigens or antibodies. Presented below is the diagnostic 
value of the main antigens and antibodies detected in the serum and CSF in patients with 
neurotuberculosis. 
6. Diagnostic value of immunological assays in studies of adults with 
neurotuberculosis 
6.1 Mycobacterial antigens detection in neurotuberculosis  
The mycobacterial antigens detection in CSF samples evidence active meningeal infection 
and could hold a diagnostic value. Hence, several M.tbc antigens have been analyzed as 
potential markers for the TB menigitis diagnosis. Moreover, quantitative determination of 
antigens could be useful for treatment monitoring. Attempts to detect mycobacterial 
antigens in neurotuberculosis have been made since 1984 employing mostly agglutination 
tests, ELISA with different variants or other methods (Venkatesh et al, 2007; Sumi et al, 2002; 
Radhacrishnan et al, 1990; Katti, 2001; Kashyap et al, 2009). Numerous antigens were 
evaluated: 55-kDa antigen, 14 kDa, PPD, 62 kDa, ag 85 complex , 30-32 kDa protein, LAM, 
Ag Mtbc, M. tbc H37Rv. The main conclusions of these studies are listed below. 
a. Method efficiency. The specificity of methods: 69-100%. The sensitivity variation 
depended on the diagnosis criteria: in bacteriologically confirmed TB meningitis 79-
100%; 67-92% in unconfirmed cases and 50-100% in both confirmed and unconfirmed 
cases. 
b. Comments. The evaluated antigens were extremely different for each study. The 
sensitivity of methods was highly variable too. No method or specific antigen rendered 
a higher efficiency, although more studies have confirmed the presence of 30Kda 
antigen (ag 85 complex) in the CSF and simultaneous use of more antigens improved 
the methods sensitivity. The highly variable results could derive from the reduced level 
of antigen in the CSF, as well as from the lack of complete information connected with 
the precise type of antigens released in the CSF in TB meningitis. 
6.2 Antimycobacterial antibodies detection in neurotuberculosis 
Irrespective of localisation, antigentic stimulation in mycobacteria infections induces the 
synthesis of specific antibodies in the serum. In neurological localizations however, 
antibodies also appear in the CSF as a result of intratechal synthesis (Sindic et al, 1990; 
Kinmann et al, 1981; Kalish et al, 1983) and active secretion by choroidal plexuses. False 
positive antibodies in the CSF are possible in areas endemic for TB, where healthy persons 
or patients with pulmonary TB present high serum levels of antimycobacterial antibodies 
able to difusse from the serum to the CSF. The assesment of the intratechal synthesis of 
antimycobacterial antibodies could help ascertain such false positive reactions. Most studies 
analyzing the presence of the antimycobacterial antibodies in CSF were performed in 
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imunocompetent adults with TB meningitis. The detected antibodies involved more 
antigens either isolated or simultaneous (LAM, PPD, A60, M.tbc, Ag 5, 14kDa, 19 kDa,  
27 kDa, 30 kDa, 35 kDa, 40 kDa, Ag H37Ra, LAM, 30 kDa, 65 kDa heat shock protein, ESAT-
6 antigen). In addition, most authors focused on the detection of IgG type antibodies using 
ELISA. Below are the main findings of these studies (Thakur & Mandal, 1996; Maheshwari 
et al, 2000; Patil1et al, 1996; Kashyap et al 2009; Mudaliar et al, 2006).  
a. Method’s efficiency. The specificity of antimycobacterial antibodies detection ranged 
between 92-100% but the positive predictive value was high. False positive results were 
recorded in patients who also presented pulmonary TB or as a result of cross-reactivity; 
65 antigen kDa belonging to stress proteins was most frequently involved in cross 
reactions with other bacteria. The sensitivity of methods was highly variable: 30-100% 
in the studies with a single tested antigen and 61-100% when testing multiple antigens 
Chandramuki et al, 1989; Mathai et al, 1990a). The sensitivity was correlated with 
diagnosis criteria as follows: 80-90% sensitivity in bacteriologically confirmed 
tuberculous meningitis, 30-62% sensitivity in unconfirmed cases, 58% sensitivity in 
histologically confirmed tuberculomas and 70-87% sensitivity in clinically TB 
meningitis. Large differences between studies were also noticed depending on 
antibodies detection (for LAM, the sensitivity varied between 58-85% and for A60, the 
sensitivity ranged from 38 to 100%). 
b. Comments. Almost all studies were perfomed in patients with TB meningitis. 
Nevertheless, a study on tuberculoma revealed A60 antibodies in these patients too. 
This indicates the potential use of the serodiagnosis in localized forms of 
neurotuberculosis, in which noninvasive diagnotic tools are presently unavailable. 
The variability of the recorded results was connected with more factors: 1) the use of 
different antigens (several studies indicate LAM antigen as immunodominant in the 
CSF; 2) the use of different dilutions: higher dilutions of the CSF decreased the 
sensitivity; 3) the immune status of different patients: low antibody detection in 
immunodepressed patients (only 10%) compared to immunocompetent hosts (50%);  
4) almost all studies analyzed IgG antibodies, while only few also considered IgM or 
IgA. The antigens which induced IgM antimycobacterial antibodies were different 
from those responsible for IgG. IgG antibodies were mostly directed against LAM or 
14 kDa antigen (74% of the total patients), suggesting that using these antigens could 
raise the efficiency. 5) some studies disclosed that simultaneous detection of serum 
and CSF antimycobacterial antibodies improved the CSF results compared to serum 
detection only. (Srivastava et al, 1994); however other studies reported inferior CSF 
sensitivity compared to the serum sensitivity.(Ghoshal et al, 2003). 6) the sensitivity 
of antibodies detection increased during treatment with 18% for both IgG and IgA 
detection. 
Conclusion. There is a large number of serological studies dedicated to neurotuberculosis, 
with extremely different results. They are hard to compare as a result of using different 
study protocols and different antibodies detection. Despite the unconfindence which these 
studies arose, serologic diagnosis is widely used in poor countries. The standardisation of 
the methods in what regards the recommended antigens (type, concentration) and the 
immunological assay, could help improve the immunological diagnosis. One advantage of 
this method is the CSF specificity of antigens and intrathecal antimycobacterial antibodies 
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synthesis and also the increased antibody level during antituberculous treatment, which 
renders this method useful for a retrospective diagnosis. 
6.3 Intrathecal synthesis of antimycobacterial antibodies in neurotuberculosis 
TB meningitis prompts a vigorous humoral local response proved by CSF intrathecal 
synthesis of antimycobacterial antibodies. Sindic proved that most antibodies synthesized 
intrathecally are directed against antigen A60 (Sindic et al, 1990). He also revealed the 
presence of Ig in the subarahnoidian space after 14-27 days of disease and their persistence 
after several years. A higher Ig G index is presently regarded as a strong argument in favor 
of the humoral local response induced by mycobacteria. All the same not all Ig detected in 
the CSF belong to antimycobacterial antibodies. Unspecific IgG were also found in other 
diseases affecting the CNS as a results of an immunosuppresive abberation. This immune 
impairment allows B cell multiplication and antibody persistence accounting for false 
positive results. Fals positive CSF results could also be found after passive transfer of 
antimycobacterial antibodies from the serum in the subarachnoid space. The mathematical 
evaluation of the intrathecal synthesis takes into account the presence of antibodies and IgG 
level in serum and CSF could highlight these false positive results. 
6.4 Personal contribution. The intrathecal synthesis of antimycobacterial antibodies 
in patients with TB meningitis 
The sole presence of antimycobacterial antibodies in the CSF cannot define the local 
inflammatory response since any form of TB accompanied by high titres of antibodies could 
promote their passive transfer in the CSF. The intrathecal synthesis was instead 
acknowledged as a typical finding in neurotuberculosis and an alternative for improving the 
specificity and positive predictive value of diagnosis in TB meningitis.The aim of our study 
was to evaluate the presence of antimycobacterial antibodies released as a result of the 
intrathecal synthesis in TB meningitis and to differentiate them from unspecific Ig.  
Subjects. The study was performed on 21 adult patients with TB meningitis. A total of 34 
CSF samples were collected, all having proved positive for antimycobacterial antibodies. 
The samples were collected after starting the antituberculous treatment, between 3 and 140 
days after the clinical onset of the disease. Diagnosis criteria of TB meningitis were based on 
clinical characteristic features, CSF characteristic features (CSF lymphocytosis, increased 
protein and decreased sugar), evidence of pulmonary or extrapulmonary TB and positivity 
of CSF Lowenstein culture (for 3 patients only). Antimycobacterial antibodies were detected 
through ELISA using glycolipidic (GL) antigens and A60antigen.  
Methods. Two types of comparative antigens were used for ELISA: GL antigen (0,1 ml sol of 
10micrograms/ml of purified glycolipid in hexan obtained from Cantacuzino laboratories, 
Romania) and A60 (Andaelisa mycobacteria IgG, IgM, IgA kits, from Anda Biologicals, 
Strasbourg, France).  
a. Elisa anti GL antigen detection method steps: 0,1 ml of ½ diluted CSF and 0,1 ml of 
conjugate (protein A–peroxidase) were distributed in microplates at 370 C for 1 hour; 0,1 
ml OPD (peroxide and ortophenylendiamine) substrate in citric acid-sodium citrate 
buffer, 0,1 M, pH =5, was used. The reaction was prolonged for 30 minutes, at 370C, at 
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dark. The optical densities (OD) were read with a Multiscan MCC Reader, at 450 nm. 
Serum Ig isolated from immunised rabbits with Mtbc suspension were used as positive 
controls. Cut off was established at two standard deviations above the level considered 
normal. The level of antibodies was expressed in international units (UI). The baseline 
serounit for the CSF fluid was 0 UI.  
b. Elisa antiA60 detection steps: the CSF fluid was diluted 1/10 according to the kit 
instructions; anti-human IgG, IgA, IgM were conjugated to peroxidase (one hour at 
370C). The baseline serounits were: 125 for IgG, 200 for IgA serounits and 0.8 for IgM 
antibodies. Supplementary analysis in all subjects included: serum and CSF albumin 
expressed in mg/ml) (Ortodiagnosis) and serum and CSF Ig (radial passive 
immunodifussion). Albumin index, IgG index and IgG intratechal synthesis were 
calculated using the following mathematical formula (Tibbling 1977):  
1. Albumin index (mg/ml)= CSF albumin/ serum albumin ratio. The normal value of 
CSF albumin was considered < 35mg% and between 3500-5000 mg% for serum 
albumin. The normal value of the albumin index is < 7x10-3 (0.007). Higher values 
suggest the permeability of the hematomeningeal barrier and the possibility of a 
passive transfer of antimycobacterial antibodies from the blood to the CSF.  
2. IgG index (mg/ml)= (CSF IgG/serum IgG) / (CSF albumin /serum albumin) ratio.The 
normal value of the IgG index is ≤0.7. Higher values indicate increased IgG synthesis.  
3. IgG intratechal synthesis of antimycobacterial antibodies was acquired using the 
formula: (CSF antimycobacterial antibodies of IgG type/CSF IgG) / (serum 
antimycobacterial antibodies of IgG type/serum IgG) ratio. Antimycobacterial 
antibodies of IgG type were measured in ELISA units. Serum and CSF IgG were 
quantified in mg/ml. The normal value of the intratechal synthesis calculated using this 
formula is < 1.  
Results. The intrathecal synthesis was present 3 days after clinical onset and persisted up to 
140 days after onset. The intrathecal synthesis against GL antigen was assessed in 31 samples 
while anti A60 antibodies were assessed only in 19 samples, out of the total of 34 CSF samples. 
19 CSF samples were studied comparatively for the intrathecal synthesis of anti GL antibodies 
and antiA60: anti GL antibodies were detected in 7 samples only (22,58%) and anti A60 in 15 
patients (78,94%).Eighteen from the 19 CSF samples (94,73%) presented the intrathecal 
synthesis of either anti GL antibodies or anti A60.Results are displayed in table 1.  
 
Antimycobacterial 





CSF samples positive 
for the intrathecal 
antibody synthesis 
CSF samples 




positive for  






7 from 31 samples 
(22,58%) 
33 from 34 
samples 
(97,05%)  




19 15 from 19 (78,94%) 
GL and A60 IgG 
antibodies 
19 18 from 19 (94,73%)  
Table 1. Results of the albumin index, IgG index and the intrathecal synthesis of 
antimycobacterial anti GL and A60 in patients with TB meningitis 
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Observations. High values of the IgG index were recorded in 70, 58% cases and high values 
of the albumin index suggesting an increased permeability of the hematomeningeal barrier 
were noticed in 97,05% of patients. Only a part of the patients positive for CSF anti GL or 
A60 antibodies also exhibited an intrathecal synthesis. This finding confirms the transfer of 
antibodies from the serum into the CSF, through the hematomenigeal barrier. We also 
observed a significantly lower anti GL intrathecal synthesis compared to anti A60. In our 
study the simultaneous detection of intrathecal synthesis increased the CSF detection of 
antimycobacterial antibodies.  
Conclusions. This study recorded the intrathecal synthesis of at least one type of 
antimycobacterial antibodies (GL or A60) in 94,73% of the TB meningitis patients even after 
specific treatment starting. The current study is also one of the few confirming the 
intrathecal synthesis of antimycobacterial antibodies in TB meningitis. Our findings support 
the value of the immunologic diagnosis, be it retrospective, after specific treatment starting. 
7. Diagnostic value of immunological assays in children with 
neurotuberculosis 
TB meningitis in children develops after hematogenic dissemination from the pulmonary 
infection site. Thus it manifests as a progressive primary disease, while in adults it 
commonly arises as a relapsing form of TB. The neurologic signs and symptoms become 
obvious 2 weeks after the onset. CSF changes are frequently unspecific and cases with a 
normal CSF examination have also been described in TB encephalopathy. The first obstacle 
in the diagnosis lies in obtaining adequate CSF and sputum samples. Moreover the 
bacteriological diagnosis in TB meningitis is disappointing: acid fast bacilli stain is positive 
in only 15% of cases and culture in only 30% of cases. The prognosis is poor and a rapid 
diagnosis is imperious. Most treatment regimens in children TB meningitis are initiated 
based on clinical, epidemiological data and pulmonary radiological features, without a 
bacteriological confirmation. The most adequate methods in the neurotuberculosis diagnosis 
in children are the molecular techniques (Lawn & Zumla, 2011). These are rapid and 
specific, but the high cost prevents their use on a wider scale in poor countries. At the same 
time, some countries are reluctant to employ molecular techniques in the TB diagnosis in 
children (Consensus Statement on Childhood Tuberculosis, 2010). Therefore the serological 
methods could be an alternative, but there are few studies on children and their efficiency is 
variable. The lack of knowledge related to the type of antigen released in this age group 
causes highly unspecific results. The serologic diagnosis is based on antigens randomly 
chosen, considered as immunodominant in adult TB (Raja et al, 2001). However certain 
results yielded by serologic techniques deserve credit for having revealed additional 
information on the immune pathogenesis of TB in children. According to these the titre of 
antimycobacterial antibodies and TST in children under 2 years are influenced by BCG 
vaccination which prompts persistent titres of antimycobacterial antibodies. Children 
between 0-4 years display a decreased humoral immune response despite a strong cellular 
immune response. (Seth et al, 1993). Subsequently the titre of antimycobacterial antibodies 
increases with age (Delacourt et al, 1993). Children with primary lesions of TB or calcified 
lesions also present increased titres of serum antibodies. As a result there is a high risk of 
false positive reactions in TB endemic areas. Thus the serologic diagnosis of active TB is not 
regarded as a plausible alternative for diagnosis in children. In addition, the serologic 
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results in children with pulmonary and extrapulmonary TB exhibit an extremely varied 
sensitivity (20.7%-85%) (Rosen, 1990, Alde et al, 1989). Results with a better sensitivity were 
retrieved for A60, antigen 85 complex, 30 kDa or combinations of multiple antigens 
(Delacourt et al, 1993, Dayal et al, 2008, Raja et al, 2001). The specificity depends on the 
antigen used or the type of detected antibodies (Raja, 2001, Delacourt et al, 1993). There are 
also studies suggesting a correlation between the titre of antibodies and the antituberculous 
treatment. This implies the monitoring of antibodies titre in the pediatric management of 
TB. (Sireci et al, 2007). However the above mentioned results are considered of little 
practical value and irrelevant for the current diagnostic methods in TB. Other immunologic 
assays such as IGRAs although unrelated to the BCG vaccination and with a high specificity 
appear not to be advantageous in all cases of active TB in children. (Kampmann et al, 2009). 
There are few serologic studies in children with TB meningitis which displayed a high 
variable sensitivity. A comparative analysis on these studies is hindered by the diverse 
antigens used and discordant results (Dole et al, 1989; Srivastava et al, 1998) (table 9). 
Serious errors of interpretation are important for the above mentioned reasons.  
The efficiency of serologic techniques in children with neurotuberculosis is low: 
sensitivity of 30%-100% and specificity of 62-96%. The sensitivity was influenced by the CSF 
dilution, the type of detected antibody and the chosen antigen. The sensitivity was similar 
for the serum and CSF.  
Comments. ELISA was the technique most commonly used. Best results involved 
antimycobacterial antibodies A60, 30 Kda and M. bovis BCG towards Ag 5 and LAM. Some 
studies considered the detection of IgM more relevant than IgG. The detection of antigens in 
the CSF proved more useful compared to the finding of antibodies in TB meningitis.  
8. Diagnostic value of immunological assays in studies of HIV patients with 
neurotuberculosis 
The neurotuberculosis diagnosis in HIV infected patients is probably overevaluated. The TB 
patients with HIV often present miliaria forms, extrapulmonary localisations of TB and 
extensive vasculisis, accompanied by specific HIV manifestations. The difficulty to 
recognize the neurologic forms of TB increases with the advancing immunodepression. The 
low inflammatory response in HIV patients generates an atypical CSF aspect and repeated 
confusions with meningitis of other aetiology. At the same time, the TB aetiology should 
always be included in the differential diagnosis due to its frequency in the evolution of the 
HIV infection. TB meningitis usually appears as a relapse and only rarely during primary 
infection. Bacteriological confirmation is delayed and its sensitivity is under dispute: some 
authors recorded a higher number of false negative smear sample results while others 
maintained that the sensitivity is similar in both HIV and non-HIV infected patients. 
Therefore in order to raise the cases diagnosed one should consider the addition of invasive 
investigations and high cost molecular techniques. The immunologic methods of diagnosis 
in immunodepressed hosts have been little evaluated. HIV patients display a decreasing Th1 
count, sustaining the Th2 stimulation of B cells and the synthesis of antimycobacterial 
antibodies. Specific tests of cell immunity (IGRAs, TST) are disappointing (Pai & Lewinsohn, 
2005) but the humoral immune response appears to persist for a long time. An advantage of 
the serologic diagnosis is that of the high titres of antimycobacterial antibodies in relapse 
forms which comprise the majority of TB forms in HIV patients. Certain authors observed 
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an increased IgG in the serum of HIV patients with pulmonary TB compared to controls ( 
Van Vooren et al,1994). No difference has been observed between pulmonary TB and 
extrapulmonary TB in what regards humoral immunity (Daleine et al, 1995). The essential 
difference resides in the released antigens. A serologic study in HIV patients with TB 
infection concluded that only 14 antigens induced the antibody synthesis in these patients. 
Interestingly, most antigens between 32-45KDa (except for 38 Kda) failed to elicit a humoral 
reponse (Zhou et al, 1996). The best results involved glycolipidic antigens , especially LOS, 
LAM, DAT, PGL (Patel et al, 2009) and high molecular weight proteic antigens (ag 85Kda, 
88Kda) (Laal et al, 1997). LAM positivity has been associated with HIV co-infection and low 
CD4 T cell count. Below are the conclusions of ten studies performed in patients with HIV 
and TB infection using Elisa and numerous antigens (LOS, LAM , 88kDa , PPD , 38 kDa, 88 
kDa, A60 or antigen combinations such as PPD and DAT, PPD and SLIV or PPD and LAM.  
Main findings. Various studies revealed an extremely variable sensitivity (0-95%), not only 
for different antigens included in the same study, but also for the same antigen in 
different studies (such as the high variable sensitivity for LAM in different studies: 35-
95%). Only the selection of LOS antigen has led to concordant results between studies. 
Despite the dysfunctional cellular immune responses in HIV patients, several 
investigators have reported the presence of antibodies against M. tbc, TB16.3, TB9.7, MPT 
51, MTB 81 and 88 kDa antigens (Laal et al, 1997). Comparative studies also revealed that 
the sensitivity for certain antigens (PPD, M.tbc) doubles in patients who are HIV negative 
compared to HIV positive. Moreover the sensitivity is higher in HIV patients compared to 
AIDS patients. However the level of anti A60 IgG remains elevated in patients with AIDS 
or with a negative TST result. Despite the low sensitivity the specificity of the Mycodot 
test was high. 
Comments. Secondary TB elicits a stronger serologic response than primary TB and could 
account for the differences between the different groups of patients (Maes, 1991). 
However none of the mentioned studies classified the patients as primary or secondary 
TB. On the other hand an attempt to classify according to the bacteriological confirmation 
revealed a higher detection sensitivity for antimycobacterial antibodies in patients with 
confirmed TB (57%) than in patients with unconfirmed TB (30%) (Kameswaran et al, 
2002). Antimycobacterial antibodies could predict tuberculosis in HIV patients in some 
studies. A study by Amicosante proved the appearance of antimycobacterial antibodies 
one year before the clinical onset of tuberculosis in 67% of HIV infected patients. 
(Amicosante et al, 1994). The early prediction and diagnosis of neurotuberculosis rendered 
by antibodies are extremely important for an early starting of antituberculous 
chemotherapy. Unfortunately only few HIV patients with neurotuberculosis are recorded 
in the evaluation of extrapulmonary TB and it is difficult to estimate the real value of 
serologic methods.  
9. Diagnostic value of immunological assays in patients with neurologic 
nonmycobacterial infections  
Nontuberculous mycobacteria infections with neurologic or systemic localizations exhibit a 
low titre of IgG (Oliver et al, 2001). In addition the presence of corresponding antibodies in 
HIV patients suggests colonization (usually involving the digestive tract) rather than 
infection (Maes 1991). Thus studies on patients with AIDS and disseminated infection with 
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M.avium failed to detect any IgG antimycobacterial antibodies in the serum, unlike patients 
with AIDS and pulmonary infection with M.avium (Daniel et al, 1990). A study on the IgG, 
IgM, IgA released against antigen LAM has triggered no immune response in mycobacteria 
infections other than TB (Demkow et al, 2006). There are also studies upholding the 
possibility of a serologic diagnosis in HIV patients with nontuberculous mycobacteria 
infection using antigens extracted from PPD-B /M. intracellulare, PPD-Y/M. kansasii, PPD-
F/M. fortuitum) Nevertheless the serologic diagnosis is presently impractical in the case of 
nontuberculous mycobacteria infections and there are no available studies regarding HIV 
patients with neurotuberculosis. 
10. The interpretation of serologic results in the diagnosis of 
neurotuberculosis. Reasons for false positive and negative results 
Immunoenzymatic techniques are the most frequently used techniques for the detection of 
antimycobacterial antibodies in the CSF. The detection of CSF and serum antimycobacterial 
antibodies through such methods is specific, inexpensive, rapid, but displays a moderate 
sensitivity and requires a correct interpretation of the data. 
Reasons for false negative results. Most false negative results are related to the low level of 
antimycobacterial antibodies in the serum or CSF, along with inadequate technical 
parameters. The low titre of antibodies could be the consequence of: a) decreased antigenic 
stimulation induced by reduced metabolism of mycobacteria; b) reduced antibodies 
synthesis as a result of a congenital or acquired immunodeficiency; c) antigen fixation in the 
immune complexes; d) early detection. The use of inadequate technical parameters 
correlates with: a) a cut off too highly set; b) too high dilutions (the current CSF dilutions of 
1/10 appear to exceed the titre of antibodies); c) belated CSF processing; d) improper storing 
conditions.  
Reasons for false positive results in the CSF: a) excessive amount of serum antibodies able 
to cross the blood barier (a finding usually related to pulmonary TB); b) cross reaction with 
other infections (Nocardia, Corynebacterium) , the rheumatoid factor, or other diseases 
(sarcoidosis, pulmonary neoplasm, autoimmune diseases); c) immune hiperreactivity unable 
to suppress the antibody synthesis after the disappearance of the stimulus; f) insufficient 
purification of the antigens; g) high prevalence of TB and a low cut-off. 
11. Improvement possibilities of serologic techniques in neurotuberculosis  
The improvement of immunologic results in neurotuberculosis diagnosis is first related to 
the knowledge advance of TB immunopathology. The current improvement strategies focus 
on the following: a) The discovery of highly specific antigens; b) Polyproteins or multiple 
antigens concurrent detection; c) Cut-off value adapted to the geographic area TB 
endemicity and to the CSF sample (the predicted cut off value for the CSF is of 40 serounits 
of IgG instead of 200 serounits required by pulmonary TB); d) The removal of immune 
complexes; e) Repeated serologic detection after onset and during treatment;  
f) Simultaneous screening for antibodies IgM, IgG, IgA; g) Simultaneous detection of 
antibodies and antigenes using rapid techniques; h)The use of low dilutions for the 
immunosuppressed patients); i) Intrathecal synthesis detection; j) Correlation with 
www.intechopen.com
 
Understanding Tuberculosis – Global Experiences and Innovative Approaches to the Diagnosis 
 
164 
immunologic markers (the CD4 level, immunogram) for a correct interpretation of the 
immune status. 
12. Conclusions 
a. The value and limits of the immunologic diagnosis in NTB 
The detection of mycobacteria antigens and antimycobacterial antibodies in the CSF, as well 
as in the serum of patients with neurotuberculosis could augment the diagnosis suspicion 
and ensure a rapid treatment. Increasing the efficiency of the immunologic diagnosis in 
neurotuberculosis requires antigens that are specific for neurological localizations as well as 
standardized and sensitive methods. Immunoserological studies on neurotuberculosis 
generally involve methods with a good specificity and acceptable senzitivity. The rapidity 
and increased specificity are the main advantages of these methods. Still, these diagnostic 
methods cannot replace the bacteriological exam and are presently unstandardised, which 
hinders the results comparison. In addition, the correct interpretation requires complex data 
(not always available) related to the onset, treatment, medical history, other localizations of 
tuberculosis and the immunologic status. In the absence of these data, the results obtained 
through serological methods cannot be relevant.  
b. The possibilities of performing the immunologic diagnosis in NTB 
Despite the numerous diagnostic tools presently available, the neurologic forms of TB often 
remain undetected and lead to an increased mortality. Neurologic localizations are mostly 
smear negative and require a rapid diagnosis. The only rapid diagnosis method employs 
molecular techniques which are too expensive for developing countries. Moreover, starting 
antituberculous treatment before the collection of specific pathological products decreases 
the sensitivity of both bacteriological and molecular methods. The immunologic methods 
are inexpensive and could also be used after treatment starting. The rapid methods (Dot) do 
not even require trained personnel, the results are available without delay and the reagents 
are easy to store. As long as the interpretation of the results is correct, the serological 
methods deliver significant information and a rapid orientation in the diagnosis at a low 
cost.  
c. The practical value of the immunologic diagnosis as a complementary method in 
developing countries with a high prevalence of TB 
The immunologic methods studied in neurotuberculosis hold a practical value once their 
results are included in an internationally accepted algorithm for diagnosis. However, the 
use of these diagnostic methods and reports on cost-efficiency are regarded with reluctance. 
Literature data published between 2004-2008 on TB case definitions includes only 1 study 
which considers ELISA IgM detection useful in TB meningitis (Kalita et al, 2007).Three other 
studies consider that a positive TST test could exhibit only a potential utility in the diagnosis 
of TB. (Marais et al, 2010) There is also insufficient experience in order to appreciate the 
efficiency of IGRAs assays in the diagnosis of neurotuberculosis. Therefore the immunologic 
diagnosis in neurotuberculosis is not currently accepted in the international guidelines as a 
complementary diagnosis for the confirmation of the diagnosis of neurotuberculosis. 
Nevertheless serologic diagnostic methods are in use in developing countries and provide 
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rapid orientative data in TB meningitis. However each assay should be validated using 
controls from that specific area and a part of the technical criteria are also to be adapted to 
that area in terms of cut off value and used antigens. Standardised diagnostic criteria for TB 
meningitis as well as standardised immunologic methods could render correct forthcoming 
comparisons between immunologic studies. It could also establish the real value of these 
methods especially in poor countries with a high prevalence for tuberculosis and reduced 
possibilities of diagnosis. 
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